174 related articles for article (PubMed ID: 10679969)
1. Developments in gene therapy for muscular dystrophy.
Hartigan-O'Connor D; Chamberlain JS
Microsc Res Tech; 2000 Feb 1-15; 48(3-4):223-38. PubMed ID: 10679969
[TBL] [Abstract][Full Text] [Related]
2. Herpes simplex virus vector-mediated dystrophin gene transfer and expression in MDX mouse skeletal muscle.
Akkaraju GR; Huard J; Hoffman EP; Goins WF; Pruchnic R; Watkins SC; Cohen JB; Glorioso JC
J Gene Med; 1999; 1(4):280-9. PubMed ID: 10738561
[TBL] [Abstract][Full Text] [Related]
3. Adeno-associated virus vector-mediated gene transfer into dystrophin-deficient skeletal muscles evokes enhanced immune response against the transgene product.
Yuasa K; Sakamoto M; Miyagoe-Suzuki Y; Tanouchi A; Yamamoto H; Li J; Chamberlain JS; Xiao X; Takeda S
Gene Ther; 2002 Dec; 9(23):1576-88. PubMed ID: 12424610
[TBL] [Abstract][Full Text] [Related]
4. [Development of new therapy on muscular dystrophy].
Takeda S
Rinsho Shinkeigaku; 2001 Dec; 41(12):1154-6. PubMed ID: 12235824
[TBL] [Abstract][Full Text] [Related]
5. Adenovirus-mediated dystrophin minigene transfer improves muscle strength in adult dystrophic (MDX) mice.
Yang L; Lochmuller H; Luo J; Massie B; Nalbantoglu J; Karpati G; Petrof BJ
Gene Ther; 1998 Mar; 5(3):369-79. PubMed ID: 9614557
[TBL] [Abstract][Full Text] [Related]
6. rAAV vector-mediated sarcogylcan gene transfer in a hamster model for limb girdle muscular dystrophy.
Li J; Dressman D; Tsao YP; Sakamoto A; Hoffman EP; Xiao X
Gene Ther; 1999 Jan; 6(1):74-82. PubMed ID: 10341878
[TBL] [Abstract][Full Text] [Related]
7. Progress toward gene therapy of Duchenne muscular dystrophy.
Hartigan-O'Connor D; Chamberlain JS
Semin Neurol; 1999; 19(3):323-32. PubMed ID: 12194388
[TBL] [Abstract][Full Text] [Related]
8. The short MCK1350 promoter/enhancer allows for sufficient dystrophin expression in skeletal muscles of mdx mice.
Larochelle N; Oualikene W; Dunant P; Massie B; Karpati G; Nalbantoglu J; Lochmuller H
Biochem Biophys Res Commun; 2002 Apr; 292(3):626-31. PubMed ID: 11922612
[TBL] [Abstract][Full Text] [Related]
9. Functional enhancement of skeletal muscle by gene transfer.
Gregorevic P; Chamberlain JS
Phys Med Rehabil Clin N Am; 2005 Nov; 16(4):875-87, vii-viii. PubMed ID: 16214049
[No Abstract] [Full Text] [Related]
10. The potential for gene therapy in Duchenne muscular dystrophy and other genetic muscle diseases.
Karpati G; Acsadi G
Muscle Nerve; 1993 Nov; 16(11):1141-53. PubMed ID: 8413366
[TBL] [Abstract][Full Text] [Related]
11. Full-length dystrophin gene transfer to the mdx mouse in utero.
Reay DP; Bilbao R; Koppanati BM; Cai L; O'Day TL; Jiang Z; Zheng H; Watchko JF; Clemens PR
Gene Ther; 2008 Apr; 15(7):531-6. PubMed ID: 18273052
[TBL] [Abstract][Full Text] [Related]
12. Construction and analysis of compact muscle-specific promoters for AAV vectors.
Wang B; Li J; Fu FH; Chen C; Zhu X; Zhou L; Jiang X; Xiao X
Gene Ther; 2008 Nov; 15(22):1489-99. PubMed ID: 18563184
[TBL] [Abstract][Full Text] [Related]
13. [Gene therapy to muscle diseases: perspective and issues on basic research].
Takeda S
Nihon Rinsho; 1997 Dec; 55(12):3114-9. PubMed ID: 9436420
[TBL] [Abstract][Full Text] [Related]
14. Efficient and long-term intracardiac gene transfer in delta-sarcoglycan-deficiency hamster by adeno-associated virus-2 vectors.
Li J; Wang D; Qian S; Chen Z; Zhu T; Xiao X
Gene Ther; 2003 Oct; 10(21):1807-13. PubMed ID: 12960970
[TBL] [Abstract][Full Text] [Related]
15. A canine minidystrophin is functional and therapeutic in mdx mice.
Wang B; Li J; Qiao C; Chen C; Hu P; Zhu X; Zhou L; Bogan J; Kornegay J; Xiao X
Gene Ther; 2008 Aug; 15(15):1099-106. PubMed ID: 18432277
[TBL] [Abstract][Full Text] [Related]
16. AAV vector-mediated microdystrophin expression in a relatively small percentage of mdx myofibers improved the mdx phenotype.
Yoshimura M; Sakamoto M; Ikemoto M; Mochizuki Y; Yuasa K; Miyagoe-Suzuki Y; Takeda S
Mol Ther; 2004 Nov; 10(5):821-8. PubMed ID: 15509500
[TBL] [Abstract][Full Text] [Related]
17. Effective repetitive dystrophin gene transfer into skeletal muscle of adult mdx mice using a helper-dependent adenovirus vector expressing the coxsackievirus and adenovirus receptor (CAR) and dystrophin.
Uchida Y; Maeda Y; Kimura E; Yamashita S; Nishida Y; Arima T; Hirano T; Uyama E; Mita S; Uchino M
J Gene Med; 2005 Aug; 7(8):1010-22. PubMed ID: 15756716
[TBL] [Abstract][Full Text] [Related]
18. Stable transduction of myogenic cells with lentiviral vectors expressing a minidystrophin.
Li S; Kimura E; Fall BM; Reyes M; Angello JC; Welikson R; Hauschka SD; Chamberlain JS
Gene Ther; 2005 Jul; 12(14):1099-108. PubMed ID: 15759015
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic improvement of dystrophic muscles by rAAV/microdystrophin vectors is augmented by Igf1 codelivery.
Abmayr S; Gregorevic P; Allen JM; Chamberlain JS
Mol Ther; 2005 Sep; 12(3):441-50. PubMed ID: 16099410
[TBL] [Abstract][Full Text] [Related]
20. Recombinant adeno-associated viral (rAAV) vectors as therapeutic tools for Duchenne muscular dystrophy (DMD).
Athanasopoulos T; Graham IR; Foster H; Dickson G
Gene Ther; 2004 Oct; 11 Suppl 1():S109-21. PubMed ID: 15454965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
